IRONWOOD PHARMACEUTICALS INC
IRWDUS売上高
$296M
百万USD
営業利益
$99M
百万USD
純利益
$24M
百万USD
ROE
-9.2%
最新FY
EPS
$0.15
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $89M | $40M | $0.25 |
| FY2021 | Q2 | $104M | $391M | $2.39 |
| FY2021 | Q3 | $104M | $56M | $0.34 |
| FY2021 | FY | $414M | $528M | $3.21 |
| FY2022 | Q1 | $97M | $37M | $0.21 |
| FY2022 | Q3 | $109M | $50M | $0.28 |
| FY2022 | FY | $411M | $175M | $0.96 |
| FY2023 | Q1 | $104M | $46M | $0.25 |
| FY2023 | Q2 | $107M | $-1.1B | $-6.84 |
| FY2023 | Q3 | $114M | $15M | $0.09 |
| FY2023 | FY | $443M | $-1.0B | $-6.45 |
| FY2024 | Q1 | $75M | $-4M | $-0.03 |
| FY2024 | Q2 | $94M | $-1M | $-0.01 |
| FY2024 | Q3 | $92M | $4M | $0.02 |
| FY2024 | FY | $351M | $1M | $0.01 |
| FY2025 | Q1 | $41M | $-37M | $-0.23 |
| FY2025 | Q2 | $85M | $24M | $0.14 |
| FY2025 | Q3 | $122M | $40M | $0.23 |
| FY2025 | FY | $296M | $24M | $0.15 |
| FY2026 | Q1 | $107M | $41M | $0.24 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $347M | $428M | $390M | $414M | $411M | $443M | $351M | $296M |
| 営業利益 | $-52M | $-77M | $-239M | $120M | $143M | $232M | $250M | $-945M | $93M | $99M |
| 純利益 | - | $-117M | $-282M | $22M | $106M | $528M | $175M | $-1.0B | $1M | $24M |
| 総資産 | $710M | $606M | $332M | $403M | $559M | $1.1B | $1.1B | $471M | $351M | $397M |
| 純資産 | - | - | - | - | - | - | $652M | $-346M | $-301M | - |
| 自己資本 | $67M | $10M | $-196M | $-93M | $63M | $606M | $652M | $-346M | $-301M | $-262M |
| 営業CF | $-25M | $-100M | $-71M | $11M | $169M | $262M | $274M | $183M | $104M | $127M |
| EPS | - | - | - | $0.14 | $0.66 | $3.21 | $0.96 | $-6.45 | $0.01 | $0.15 |
| BPS | - | - | $-1.27 | $-0.59 | $0.39 | $3.81 | $4.23 | $-2.21 | $-1.86 | $-1.61 |
| ROE | - | -1187.4% | 143.8% | -23.1% | 169.5% | 87.2% | 26.8% | 289.4% | -0.3% | -9.2% |